ST Sinopep received the drug registration certificate for injectable Acetate of Sunitinib and Agomelatine tablets

ST Sinopep recently received the drug registration certificates for injectable Acetate of Cetrorelix and Agomelatine tablets approved by the National Medical Products Administration. Acetate of Cetrorelix has unique clinical advantages in assisted reproductive technology, with a fast onset, high safety, and mild injection reactions. Agomelatine, as a new type of antidepressant, has a dual mechanism of action, rapidly improving sleep without affecting daytime function, and has a low risk of sexual dysfunction and good tolerance